Katrin Hübner

Katrin Hübner

Auto-generated profile, based on publicly available information

Katrin Hübner

Section of Molecular Immunology, Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2010 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
CGChristoph Gille
Christoph Gille
CBChristian Bölling
Christian Bölling
AHAndreas Hoppe
Andreas Hoppe
SBSascha Bulik
Sascha Bulik
SHSabrina Hoffmann
Sabrina Hoffmann
Hermann-Georg HolzhütterHermann-Georg Holzhütter
Hermann-Georg Holzhütter
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

14 November 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JLJie Liang
Jie Liang
BJBeate Jahraus
Beate Jahraus
EBEmre Balta
Emre Balta
JZJacqueline D. Ziegler
Jacqueline D. Ziegler
KHKatrin Hübner
Katrin Hübner
YSYvonne Samstag
Yvonne Samstag
The activity and function of T-cells are influenced by the intra- and extracellular redox milieu. Oxidative stress induces hypo responsiveness of untransformed T-cells. Vice versa increased glutathione (GSH) levels or decreased levels of reactive oxygen species (ROS) prime T-cell metabolism for inflammation, e.g., in rheumatoid arthritis. Therefore, balancing the T-cell redox milieu may represent a promising new option for therapeutic immune modulation. Here we show that sulforaphane (SFN), a compound derived from plants of the Brassicaceae family, e.g., broccoli, induces a pro-oxidative state in untransformed human T-cells of healthy donors or RA patients. This manifested as an increase of intracellular ROS and a marked decrease of GSH. Consistently, increased global cysteine sulfenylation was detected. Importantly, a major target for SFN-mediated protein oxidation was STAT3, a transcription factor involved in the regulation of TH17-related genes. Accordingly, SFN significantly inhibited the activation of untransformed human T-cells derived from healthy donors or RA patients, and downregulated the expression of the transcription factor RORγt, and the TH17-related cytokines IL-17A, IL-17F, and IL-22, which play a major role within the pathophysiology of many chronic inflammatory/autoimmune diseases. The inhibitory effects of SFN could be abolished by exogenously supplied GSH and by the GSH replenishing antioxidant N-acetylcysteine (NAC). Together, our study provides mechanistic insights into the mode of action of the natural substance SFN. It specifically exerts TH17 prone immunosuppressive effects on untransformed human T-cells by decreasing GSH and accumulation of ROS. Thus, SFN may offer novel clinical options for the treatment of TH17 related chronic inflammatory/autoimmune diseases such as rheumatoid arthritis.

1 January 2019 in Advances in Biological Regulation
Verified
Journal Article
Closed access
JLJie Liang
Jie Liang
GHGertrud Maria Hänsch
Gertrud Maria Hänsch
KHKatrin Hübner
Katrin Hübner
YSYvonne Samstag
Yvonne Samstag

1 January 2016 in Journal of Cancer
Verified
Journal Article
Open access
CMChristine Mayer
Christine Mayer
SDSilvia Darb-Esfahani
Silvia Darb-Esfahani
AMAnne-Sophie Meyer
Anne-Sophie Meyer
KHKatrin Hübner
Katrin Hübner
JRJoachim Rom
Joachim Rom
MGMatthias M. Gaida
Matthias M. Gaida
Background: Ovarian cancer (OvCa) is a highly aggressive malignoma with a tumor-promoting microenvironment. Infiltration of polymorphonuclear neutrophils (PMN) is frequently seen, raising the question of their impact on tumor development. In that context, effects of PMN on human ovarian cancer cells were assessed.

26 July 2011 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
KHKatrin Hübner
Katrin Hübner
SSSven Sahle
Sven Sahle
UKUrsula Kummer
Ursula Kummer

9 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
EBEmre Balta
Emre Balta
RHRobert Hardt
Robert Hardt
JLJie Liang
Jie Liang
HKHenning Kirchgessner
Henning Kirchgessner
COChristian Orlik
Christian Orlik
YSYvonne Samstag
Yvonne Samstag
Several antitumor therapies work by increasing reactive oxygen species (ROS) within the tumor micromilieu. Here, we reveal that L-plastin (LPL), an established tumor marker, is reversibly regulated by ROS-induced thiol oxidation on Cys101, which forms a disulfide bridge with Cys42. LPL reduction is mediated by the Thioredoxin1 (TRX1) system, as shown by TRX1 trapping, TRX1 knockdown and blockade of Thioredoxin1 reductase (TRXR1) with auranofin. LPL oxidation diminishes its actin-bundling capacity. Ratiometric imaging using an LPL-roGFP-Orp1 fusion protein and a dimedone-based proximity ligation assay (PLA) reveal that LPL oxidation occurs primarily in actin-based cellular extrusions and strongly inhibits cell spreading and filopodial extension formation in tumor cells. This effect is accompanied by decreased tumor cell migration, invasion and extracellular matrix (ECM) degradation. Since LPL oxidation occurs following treatment of tumors with auranofin or γ-irradiation, it may be a molecular mechanism contributing to the effectiveness of tumor treatment with redox-altering therapies.